Your browser doesn't support javascript.
loading
Transethnic analysis of the human leukocyte antigen region for ulcerative colitis reveals not only shared but also ethnicity-specific disease associations.
Degenhardt, Frauke; Mayr, Gabriele; Wendorff, Mareike; Boucher, Gabrielle; Ellinghaus, Eva; Ellinghaus, David; ElAbd, Hesham; Rosati, Elisa; Hübenthal, Matthias; Juzenas, Simonas; Abedian, Shifteh; Vahedi, Homayon; Thelma, B K; Yang, Suk-Kyun; Ye, Byong Duk; Cheon, Jae Hee; Datta, Lisa Wu; Daryani, Naser Ebrahim; Ellul, Pierre; Esaki, Motohiro; Fuyuno, Yuta; McGovern, Dermot P B; Haritunians, Talin; Hong, Myhunghee; Juyal, Garima; Jung, Eun Suk; Kubo, Michiaki; Kugathasan, Subra; Lenz, Tobias L; Leslie, Stephen; Malekzadeh, Reza; Midha, Vandana; Motyer, Allan; Ng, Siew C; Okou, David T; Raychaudhuri, Soumya; Schembri, John; Schreiber, Stefan; Song, Kyuyoung; Sood, Ajit; Takahashi, Atsushi; Torres, Esther A; Umeno, Junji; Alizadeh, Behrooz Z; Weersma, Rinse K; Wong, Sunny H; Yamazaki, Keiko; Karlsen, Tom H; Rioux, John D; Brant, Steven R.
Afiliação
  • Degenhardt F; Institute of Clinical Molecular Biology, Christian-Albrechts-University, 24105 Kiel, Germany.
  • Mayr G; Institute of Clinical Molecular Biology, Christian-Albrechts-University, 24105 Kiel, Germany.
  • Wendorff M; Institute of Clinical Molecular Biology, Christian-Albrechts-University, 24105 Kiel, Germany.
  • Boucher G; Research Center, Montréal Heart Institute, Université de Montréal and the Montréal Heart Institute, Montréal, Québec H1T 1C8, Canada.
  • Ellinghaus E; K.G. Jebsen Inflammation Research Centre, Institute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway.
  • Ellinghaus D; Institute of Clinical Molecular Biology, Christian-Albrechts-University, 24105 Kiel, Germany.
  • ElAbd H; Norwegian PSC Research Center, Department of Transplantation Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University Hospital Rikshospitalet, 0372 Oslo, Norway.
  • Rosati E; Institute of Clinical Molecular Biology, Christian-Albrechts-University, 24105 Kiel, Germany.
  • Hübenthal M; Institute of Clinical Molecular Biology, Christian-Albrechts-University, 24105 Kiel, Germany.
  • Juzenas S; Institute of Clinical Molecular Biology, Christian-Albrechts-University, 24105 Kiel, Germany.
  • Abedian S; Department of Dermatology, Venerology and Allergy, University Hospital Schleswig-Holstein, 24105 Kiel, Germany.
  • Vahedi H; Institute of Clinical Molecular Biology, Christian-Albrechts-University, 24105 Kiel, Germany.
  • Thelma BK; Department of Epidemiology, University Medical Center Groningen, 9713 Groningen, The Netherlands.
  • Yang SK; Digestive Disease Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran 1411713135, Iran.
  • Ye BD; Digestive Disease Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran 1411713135, Iran.
  • Cheon JH; Department of Genetics, University of Delhi South Campus, New Delhi, Delhi 110021, India.
  • Datta LW; Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.
  • Daryani NE; Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.
  • Ellul P; Department of Internal Medicine and Institute of Gastroenterology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
  • Esaki M; Harvey M. and Lyn P. Meyerhoff Inflammatory Bowel Disease Center, Department of Medicine, John Hopkins University School of Medicine, Baltimore, MD 21205, USA.
  • Fuyuno Y; Department of Gastroenterology, Emam Hospital, Tehran University of Medical Sciences, Tehran 1419733141, Iran.
  • McGovern DPB; Department of Gastroenterology, Mater Dei Hospital, Msida, Malta.
  • Haritunians T; Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
  • Hong M; Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
  • Juyal G; Laboratory for Genotyping Development, Center for Integrative Medical Sciences, Riken, Yokohama 351-0198, Japan.
  • Jung ES; F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
  • Kubo M; F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
  • Kugathasan S; Department of Biochemistry and Molecular Biology, University of Ulsan College of Medicine, Seoul, 136-701 Korea.
  • Lenz TL; School of Biotechnology, Jawaharlal Nehru University, New Delhi, Delhi 110067, India.
  • Leslie S; Institute of Clinical Molecular Biology, Christian-Albrechts-University, 24105 Kiel, Germany.
  • Malekzadeh R; Department of Internal Medicine and Institute of Gastroenterology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
  • Midha V; RIKEN Center for Integrative Medical Sciences, Yokohama, 351-0198, Japan.
  • Motyer A; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.
  • Ng SC; Pediatric Institute, Children's Healthcare of Atlanta, Atlanta, GA, USA.
  • Okou DT; Research Group for Evolutionary Immunogenomics, Max Planck Institute for Evolutionary Biology, 24306 Plön, Germany.
  • Raychaudhuri S; Schools of Mathematics and Statistics and BioSciences and Melbourne Integrative Genomics, University of Melbourne, Victoria 3010, Australia.
  • Schembri J; Digestive Disease Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran 1411713135, Iran.
  • Schreiber S; Dayanand Medical College and Hospital, Ludhiana, Punjab 141001, India.
  • Song K; Schools of Mathematics and Statistics and BioSciences and Melbourne Integrative Genomics, University of Melbourne, Victoria 3010, Australia.
  • Sood A; Department of Medicine and Therapeutics, Institute of Digestive Disease, Chinese University of Hong Kong, Hong Kong.
  • Takahashi A; Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.
  • Torres EA; Center for Data Sciences, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02114, USA.
  • Umeno J; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02114, USA.
  • Alizadeh BZ; Department of Biomedical Informatics, Harvard Medical School, Boston, MA 02115, USA.
  • Weersma RK; Program in Medical and Population Genetics, Broad Institute, Cambridge, MA 02142, USA.
  • Wong SH; Centre for Genetics and Genomics Versus Arthritis, Division of Musculosceletal and Dermatological Sciences, School of Biological Sciences, University of Manchester, Manchester, UK.
  • Yamazaki K; Department of Gastroenterology, Mater Dei Hospital, Msida, Malta.
  • Karlsen TH; Institute of Clinical Molecular Biology, Christian-Albrechts-University, 24105 Kiel, Germany.
  • Rioux JD; Department of Medicine, Christian-Albrechts-University, 24105 Kiel, Germany.
  • Brant SR; Department of Biochemistry and Molecular Biology, University of Ulsan College of Medicine, Seoul, 136-701 Korea.
Hum Mol Genet ; 30(5): 356-369, 2021 04 27.
Article em En | MEDLINE | ID: mdl-33555323
ABSTRACT
Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the gut. Genetic association studies have identified the highly variable human leukocyte antigen (HLA) region as the strongest susceptibility locus for IBD and specifically DRB1*0103 as a determining factor for ulcerative colitis (UC). However, for most of the association signal such as delineation could not be made because of tight structures of linkage disequilibrium within the HLA. The aim of this study was therefore to further characterize the HLA signal using a transethnic approach. We performed a comprehensive fine mapping of single HLA alleles in UC in a cohort of 9272 individuals with African American, East Asian, Puerto Rican, Indian and Iranian descent and 40 691 previously analyzed Caucasians, additionally analyzing whole HLA haplotypes. We computationally characterized the binding of associated HLA alleles to human self-peptides and analyzed the physicochemical properties of the HLA proteins and predicted self-peptidomes. Highlighting alleles of the HLA-DRB1*15 group and their correlated HLA-DQ-DR haplotypes, we not only identified consistent associations (regarding effects directions/magnitudes) across different ethnicities but also identified population-specific signals (regarding differences in allele frequencies). We observed that DRB1*0103 is mostly present in individuals of Western European descent and hardly present in non-Caucasian individuals. We found peptides predicted to bind to risk HLA alleles to be rich in positively charged amino acids. We conclude that the HLA plays an important role for UC susceptibility across different ethnicities. This research further implicates specific features of peptides that are predicted to bind risk and protective HLA proteins.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos / Etnicidade / Colite Ulcerativa / Antígenos HLA-DQ / Predisposição Genética para Doença / Cadeias HLA-DRB1 / Antígenos HLA Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos / Etnicidade / Colite Ulcerativa / Antígenos HLA-DQ / Predisposição Genética para Doença / Cadeias HLA-DRB1 / Antígenos HLA Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article